February 26, 2021
New York, NY, Feb. 26, 2021 (GLOBE NEWSWIRE) -- George Goldsmith, Chairman & CEO, to participate in Neurop...
February 9, 2021
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Ha...
February 3, 2021
COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patien...
January 28, 2021
George Goldsmith, Chairman & CEO, to deliver opening day keynote on 3 February London, UK, Jan. 28, 2021 (...
January 8, 2021
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patie...
January 6, 2021
London, UK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care compan...
November 12, 2020
Highlights include $146.6 million IPO, continued progress with phase IIb psilocybin therapy clinical trial, st...
November 9, 2020
London, UK - 9 November 2020 COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to ac...
November 5, 2020
COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to ...
November 4, 2020
COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to ...
